Predict your next investment

Corporation

See what CB Insights has to offer

About Therapiva

Therapiva is an industrial consultant and a generics pharmaceutical company. It is a joint venture between Omnicare Drugs India and Laxai Life Sciences.

Therapiva Headquarter Location

Hyderabad, 502307,

India

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Therapiva News

Dr. Reddy’s continues sell-off to Neopharma with Hyderabad API plant

Oct 16, 2018

By Maggie Lynch Dr. Reddy’s Laboratory has decided to sell its API manufacturing plant to generics joint venture, Therapiva. Dr. Reddy’s decision to sell its active pharmaceutical ingredient (API) manufacturing plant follows the recent sale of the company’s US based manufacturing facility. The sale will include all related fixed assets, current assets, current liabilities and its employees. Dr. Reddy’s stated that the decision to divest its API manufacturing business unit is a step towards streamlining operations and optimizing costs. The company said that it will allow for a focus on manufacturing generic formulations. A spokesperson from Dr. Reddy’s told us that from this sale the company is optimistic about realizing meaningful benefits from this transaction. “However, we are not disclosing any specific financials related to anticipated cost savings,” said the spokesperson. The first sale to Neopharma was reported to be an attempt by Dr. Reddy’s to optimize global cost structures. In this sale, the company sold its antibiotics (penicillin) portfolio with the sale of its manufacturing site. The spokesperson told us that the two transactions are still unrelated despite being sold to the same buyer. Therapiva a joint venture between Omnicare drugs, a Neopharma subsidiary, and Laxai manufacturing. Copyright - Unless otherwise stated all contents of this web site are © 2018 - William Reed Business Media Ltd - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions

Therapiva Acquisitions

1 Acquisition

Therapiva acquired 1 company. Their latest acquisition was Dr. Reddys Laboratories - Hyderabad API Unit on October 15, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/15/2018

Acquired Unit

1

Date

10/15/2018

Investment Stage

Companies

Valuation

Total Funding

Note

Acquired Unit

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.